Covid-19-induced coagulopathy and observed benefits with anticoagulation

Recently, literature recognized an association between coronavirus disease-19 (COVID-19) and coagulopathy [1]. COVID-19 illness severity is positively correlated with coagulopathy markers, including prolonged prothrombin time, increased fibrin degradation products, decreased platelet count, and elevated D-dimer [2 –8]. However, the pathogenesis of COVID-19-induced coagulation and the role of anticoagulation treatment remain unclear.

Source: Transfusion and Apheresis Science - August 2, 2020 Category: Hematology Authors: Sedighe Karimzade, Vinh Dong, Osama Gamal Hassan, Akshay Raut, Ahmed Fouda, Allison Parrill, Kimberly Eaton, Nguyen Tien Huy Tags: Letter to the Editor Source Type: research